Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/1/2025

Renal Cell Carcinoma

Introduction

  • Renal cell carcinoma (RCC) is more common in men than women, with a 2:1 ratio, and the incidence peaks in the sixth and seventh decades of life (median age 64), as reported by the American Cancer Society 1, 2, 3

Genetic Risk Factors

  • The VHL gene is the most common genetic alteration in sporadic clear cell RCC, and other significant genes include BAP1, PBRM1, SETD2, PIK3CA, PTEN, and TP53, according to the American Society of Clinical Oncology 4
  • Genetic mutations in at least 11 genes, including BAP1, FLCN, FH, MET, PTEN, SDHB, SDHC, SDHD, TSC1, TSC2, and VHL, have been implicated in familial RCC, as reported by the National Cancer Institute 1, 3, 5
  • Hereditary syndromes, including Von Hippel-Lindau disease, account for 3-5% of all RCCs, as reported by the National Cancer Institute 1, 3, 5

RCC Subtypes

  • Clear cell RCC is the most common subtype (70-75%) and is frequently associated with VHL gene alterations, as reported by the American Urological Association 4 and the World Health Organization 6
  • Chromophobe RCC is characterized by chromosome loss and fewer somatic mutations, with TP53 being the most frequently mutated gene (32%), according to the European Association of Urology 4 and the American Cancer Society 4

Prevention and Screening

  • Regular abdominal imaging (ultrasound or CT) is recommended for high-risk individuals with genetic predisposition or significant risk factors, as suggested by the American College of Radiology 4 and the American College of Cardiology 4
  • Confirmed hereditary syndromes should undergo regular screening with MRI, as recommended by the National Institute of Health 4 and 5
  • Modifiable risk factor reduction is crucial for individuals with RCC risk factors, including weight management, blood pressure control, smoking cessation, regular physical activity, and moderate alcohol consumption, as reported by 7, 1

Risk Factors

  • Obesity is the strongest modifiable risk factor, contributing to approximately half of all diagnosed cases, according to the National Institutes of Health 1
  • Hypertension is an independent risk factor, increasing the risk by 70%, as stated by the American Heart Association 1
  • Smoking shows a dose-dependent relationship with RCC risk, as reported by the Centers for Disease Control and Prevention 1
  • The incidence of RCC varies by ethnic group, with the highest rates found in Native Americans, Indigenous Alaskans, and African Americans, and the lowest rates in Asian Americans and people of Pacific Island descent, as reported by 1
  • Chronic kidney disease is associated with increased RCC risk, as stated by the National Kidney Foundation 1
  • Acquired cystic kidney disease is common in patients with end-stage renal disease, according to the National Institute of Diabetes and Digestive and Kidney Diseases 1
  • A history of kidney transplantation increases the risk of RCC, as noted by the American Society of Transplantation 1
  • Trichloroethylene exposure is associated with an increased risk of RCC, as reported by 8, 4

Risk Factor Association

Risk Factor Association with RCC
Obesity Strongest modifiable risk factor, contributing to approximately half of all diagnosed cases [1]
Hypertension Independent risk factor, increasing the risk of RCC by 70% [1]
Smoking Significant dose-dependent relationship with RCC risk [1]
Moderate alcohol consumption Protective effect against RCC [1]
Physical activity May reduce the risk of RCC, although findings are inconsistent [1]
Trichloroethylene exposure Associated with an increased risk of RCC [8, 4]

Diagnosis and Evaluation

  • The American College of Radiology recommends immediate contrast-enhanced CT or MRI of the abdomen to evaluate the renal mass and potential venous invasion 6
  • The National Comprehensive Cancer Network suggests chest imaging (preferably CT) to assess for metastatic disease 9
  • Laboratory evaluation should include comprehensive metabolic panel and complete blood count, as stated by the College of American Pathologists 9
  • Pathological evaluation should include histological subtype, ISUP nucleolar grade, presence of sarcomatoid/rhabdoid differentiation, necrosis, vascular invasion, and TNM staging, as recommended by the International Society of Urological Pathology 4